Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2012

01.12.2012 | Epidemiology

Time to diagnosis and breast cancer stage by race/ethnicity

verfasst von: Erica T. Warner, Rulla M. Tamimi, Melissa E. Hughes, Rebecca A. Ottesen, Yu-Ning Wong, Stephen B. Edge, Richard L. Theriault, Douglas W. Blayney, Joyce C. Niland, Eric P. Winer, Jane C. Weeks, Ann H. Partridge

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

We examined differences in time to diagnosis by race/ethnicity, the relationship between time to diagnosis and stage, and the extent to which it explains differences in stage at diagnosis across racial/ethnic groups. Our analytic sample includes 21,427 non-Hispanic White (White), Hispanic, non-Hispanic Black (Black) and non-Hispanic Asian/Pacific Islander (Asian) women diagnosed with stage I to IV breast cancer between January 1, 2000 and December 31, 2007 at one of eight National Comprehensive Cancer Network centers. We measured time from initial abnormal mammogram or symptom to breast cancer diagnosis. Stage was classified using AJCC criteria. Initial sign of breast cancer modified the association between race/ethnicity and time to diagnosis. Among symptomatic women, median time to diagnosis ranged from 36 days among Whites to 53.6 for Blacks. Among women with abnormal mammograms, median time to diagnosis ranged from 21 days among Whites to 29 for Blacks. Blacks had the highest proportion (26 %) of Stage III or IV tumors. After accounting for time to diagnosis, the observed increased risk of stage III/IV breast cancer was reduced from 40 to 28 % among Hispanics and from 113 to 100 % among Blacks, but estimates remained statistically significant. We were unable to fully account for the higher proportion of late-stage tumors among Blacks. Blacks and Hispanics experienced longer time to diagnosis than Whites, and Blacks were more likely to be diagnosed with late-stage tumors. Longer time to diagnosis did not fully explain differences in stage between racial/ethnicity groups.
Literatur
1.
Zurück zum Zitat National Cancer Institute, Surveillance Research Program (2011) Fast Stats: An interactive tool for access to SEER cancer statistics National Cancer Institute, Surveillance Research Program (2011) Fast Stats: An interactive tool for access to SEER cancer statistics
2.
Zurück zum Zitat Tartter PI, Pace D, Frost M et al (1999) Delay in diagnosis of breast cancer. Ann Surg 229:91PubMedCrossRef Tartter PI, Pace D, Frost M et al (1999) Delay in diagnosis of breast cancer. Ann Surg 229:91PubMedCrossRef
3.
Zurück zum Zitat Arndt V, Stürmer T, Stegmaier C et al (2003) Provider delay among patients with breast cancer in Germany: a population-based study. J Clin Oncol 21:1440PubMedCrossRef Arndt V, Stürmer T, Stegmaier C et al (2003) Provider delay among patients with breast cancer in Germany: a population-based study. J Clin Oncol 21:1440PubMedCrossRef
4.
Zurück zum Zitat Gorin SS, Heck JE, Cheng B et al (2006) Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166:2244–2252PubMedCrossRef Gorin SS, Heck JE, Cheng B et al (2006) Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166:2244–2252PubMedCrossRef
5.
Zurück zum Zitat Caplan LS, Helzlsouer KJ (1992) Delay in breast cancer: a review of the literature. Public Health Rev 20:187–214PubMed Caplan LS, Helzlsouer KJ (1992) Delay in breast cancer: a review of the literature. Public Health Rev 20:187–214PubMed
6.
Zurück zum Zitat Caplan LS, Helzlsouer KJ, Shapiro S et al (1995) System delay in breast cancer in whites and blacks. Am J Epidemiol 142:804PubMed Caplan LS, Helzlsouer KJ, Shapiro S et al (1995) System delay in breast cancer in whites and blacks. Am J Epidemiol 142:804PubMed
7.
Zurück zum Zitat Wujcik D, Fair AM (2008) Barriers to diagnostic resolution after abnormal mammography: a review of the literature. Cancer Nurs 31:E16–E30PubMedCrossRef Wujcik D, Fair AM (2008) Barriers to diagnostic resolution after abnormal mammography: a review of the literature. Cancer Nurs 31:E16–E30PubMedCrossRef
8.
Zurück zum Zitat Wujcik D, Shyr Y, Li M et al (2009) Delay in diagnostic testing after abnormal mammography in low-income women. Oncol Nurs Forum 36:709–715PubMedCrossRef Wujcik D, Shyr Y, Li M et al (2009) Delay in diagnostic testing after abnormal mammography in low-income women. Oncol Nurs Forum 36:709–715PubMedCrossRef
9.
Zurück zum Zitat Gwyn K, Bondy ML, Cohen DS et al (2004) Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 100:1595–1604PubMedCrossRef Gwyn K, Bondy ML, Cohen DS et al (2004) Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 100:1595–1604PubMedCrossRef
10.
Zurück zum Zitat Richardson J, Langholz B, Bernstein L et al (1992) Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer 65:922PubMedCrossRef Richardson J, Langholz B, Bernstein L et al (1992) Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer 65:922PubMedCrossRef
11.
Zurück zum Zitat Richards MA, Smith P, Ramirez AJ et al (1999) The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 79:858PubMedCrossRef Richards MA, Smith P, Ramirez AJ et al (1999) The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 79:858PubMedCrossRef
12.
Zurück zum Zitat Richards MA, Westcombe AM, Love SB et al (1999) Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353:1119–1126PubMedCrossRef Richards MA, Westcombe AM, Love SB et al (1999) Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353:1119–1126PubMedCrossRef
13.
Zurück zum Zitat Greene FL (2002) AJCC cancer staging manual. Springer Verlag, Berlin Greene FL (2002) AJCC cancer staging manual. Springer Verlag, Berlin
14.
Zurück zum Zitat Singletary SE, Allred C, Ashley P et al (2002) Revision of the American Joint Committee on cancer staging system for breast cancer. J Clin Oncol 20:3628–3636PubMedCrossRef Singletary SE, Allred C, Ashley P et al (2002) Revision of the American Joint Committee on cancer staging system for breast cancer. J Clin Oncol 20:3628–3636PubMedCrossRef
15.
Zurück zum Zitat Weeks J (1999) Outcomes assessment in the NCCN: 1998 update. National Comprehensive Cancer Network. Oncology (Williston Park) 13:69–71 Weeks J (1999) Outcomes assessment in the NCCN: 1998 update. National Comprehensive Cancer Network. Oncology (Williston Park) 13:69–71
16.
Zurück zum Zitat Weeks JC (1997) Outcomes assessment in the NCCN. Oncology (Williston Park) 11:137–140 Weeks JC (1997) Outcomes assessment in the NCCN. Oncology (Williston Park) 11:137–140
17.
Zurück zum Zitat Niland JC (2000) NCCN outcomes research database: data collection via the Internet. Oncology (Williston Park) 14:100–103 Niland JC (2000) NCCN outcomes research database: data collection via the Internet. Oncology (Williston Park) 14:100–103
18.
Zurück zum Zitat Christian CK, Niland J, Edge SB et al (2006) A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network. Ann Surg 243:241PubMedCrossRef Christian CK, Niland J, Edge SB et al (2006) A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network. Ann Surg 243:241PubMedCrossRef
19.
Zurück zum Zitat Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 25:165–172CrossRef Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 25:165–172CrossRef
20.
Zurück zum Zitat Katz JN, Chang LC, Sangha O et al (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34:73–84PubMedCrossRef Katz JN, Chang LC, Sangha O et al (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34:73–84PubMedCrossRef
21.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef
22.
Zurück zum Zitat Adams SA, Smith ER, Hardin J et al (2009) Racial differences in follow-up of abnormal mammography findings among economically disadvantaged women. Cancer 115:5788–5797PubMedCrossRef Adams SA, Smith ER, Hardin J et al (2009) Racial differences in follow-up of abnormal mammography findings among economically disadvantaged women. Cancer 115:5788–5797PubMedCrossRef
23.
Zurück zum Zitat Kerner JF, Yedidia M, Padgett D et al (2003) Realizing the promise of breast cancer screening: clinical follow-up after abnormal screening among Black women. Prev Med 37:92–101PubMedCrossRef Kerner JF, Yedidia M, Padgett D et al (2003) Realizing the promise of breast cancer screening: clinical follow-up after abnormal screening among Black women. Prev Med 37:92–101PubMedCrossRef
24.
Zurück zum Zitat Taplin SH, Ichikawa L, Yood MU et al (2004) Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst 96:1518PubMedCrossRef Taplin SH, Ichikawa L, Yood MU et al (2004) Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst 96:1518PubMedCrossRef
25.
Zurück zum Zitat Bish A, Ramirez A, Burgess C et al (2005) Understanding why women delay in seeking help for breast cancer symptoms. J Psychosom Res 58:321–326PubMedCrossRef Bish A, Ramirez A, Burgess C et al (2005) Understanding why women delay in seeking help for breast cancer symptoms. J Psychosom Res 58:321–326PubMedCrossRef
26.
Zurück zum Zitat Smith LK, Pope C, Botha JL (2005) Patients’ help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 366:825–831PubMedCrossRef Smith LK, Pope C, Botha JL (2005) Patients’ help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 366:825–831PubMedCrossRef
27.
Zurück zum Zitat Burgess C, Ramirez A, Richards M et al (1998) Who and what influences delayed presentation in breast cancer? Br J Cancer 77:1343PubMedCrossRef Burgess C, Ramirez A, Richards M et al (1998) Who and what influences delayed presentation in breast cancer? Br J Cancer 77:1343PubMedCrossRef
28.
Zurück zum Zitat Lobb R, Allen JD, Emmons KM et al (2010) Timely care after an abnormal mammogram among low-income women in a public breast cancer screening program. Arch Intern Med 170:521–528PubMedCrossRef Lobb R, Allen JD, Emmons KM et al (2010) Timely care after an abnormal mammogram among low-income women in a public breast cancer screening program. Arch Intern Med 170:521–528PubMedCrossRef
29.
Zurück zum Zitat Gabram SGA, Lund MJB, Gardner J et al (2008) Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer 113:602–607PubMedCrossRef Gabram SGA, Lund MJB, Gardner J et al (2008) Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer 113:602–607PubMedCrossRef
30.
Zurück zum Zitat Ell K, Vourlekis B, Lee PJ et al (2007) Patient navigation and case management following an abnormal mammogram: a randomized clinical trial. Prev Med 44:26–33PubMedCrossRef Ell K, Vourlekis B, Lee PJ et al (2007) Patient navigation and case management following an abnormal mammogram: a randomized clinical trial. Prev Med 44:26–33PubMedCrossRef
31.
Zurück zum Zitat Ferrante JM, Chen PH, Kim S (2008) The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health 85:114–124PubMedCrossRef Ferrante JM, Chen PH, Kim S (2008) The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health 85:114–124PubMedCrossRef
32.
Zurück zum Zitat Baquet CR, Mishra SI, Commiskey P et al (2008) Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 100:480PubMed Baquet CR, Mishra SI, Commiskey P et al (2008) Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 100:480PubMed
33.
Zurück zum Zitat Lantz PM, Mujahid M, Schwartz K et al (2006) The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health 96:2173PubMedCrossRef Lantz PM, Mujahid M, Schwartz K et al (2006) The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health 96:2173PubMedCrossRef
34.
Zurück zum Zitat Mandelblatt J, Andrews H, Kao R et al (2010) Impact of access and social context on breast cancer stage at diagnosis. J Health Care Poor Underserved 6:342–351CrossRef Mandelblatt J, Andrews H, Kao R et al (2010) Impact of access and social context on breast cancer stage at diagnosis. J Health Care Poor Underserved 6:342–351CrossRef
35.
Zurück zum Zitat Ademuyiwa FO, Edge SB, Erwin DO et al (2011) Breast cancer racial disparities: unanswered questions. Cancer Res 71:640–644PubMedCrossRef Ademuyiwa FO, Edge SB, Erwin DO et al (2011) Breast cancer racial disparities: unanswered questions. Cancer Res 71:640–644PubMedCrossRef
36.
Zurück zum Zitat Ademuyiwa FO, Olopade OI (2003) Racial differences in genetic factors associated with breast cancer. Cancer Metastasis Rev 22:47–53PubMedCrossRef Ademuyiwa FO, Olopade OI (2003) Racial differences in genetic factors associated with breast cancer. Cancer Metastasis Rev 22:47–53PubMedCrossRef
37.
Zurück zum Zitat Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502PubMedCrossRef Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502PubMedCrossRef
38.
Zurück zum Zitat Gordon NH (2003) Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 22:55–65PubMedCrossRef Gordon NH (2003) Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 22:55–65PubMedCrossRef
39.
Zurück zum Zitat Chlebowski RT, Chen Z, Anderson GL et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439–448PubMedCrossRef Chlebowski RT, Chen Z, Anderson GL et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439–448PubMedCrossRef
40.
Zurück zum Zitat Warnecke RB, Oh A, Breen N et al (2008) Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. Am J Public Health 98:1608–1615PubMedCrossRef Warnecke RB, Oh A, Breen N et al (2008) Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. Am J Public Health 98:1608–1615PubMedCrossRef
Metadaten
Titel
Time to diagnosis and breast cancer stage by race/ethnicity
verfasst von
Erica T. Warner
Rulla M. Tamimi
Melissa E. Hughes
Rebecca A. Ottesen
Yu-Ning Wong
Stephen B. Edge
Richard L. Theriault
Douglas W. Blayney
Joyce C. Niland
Eric P. Winer
Jane C. Weeks
Ann H. Partridge
Publikationsdatum
01.12.2012
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2012
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-012-2304-1

Weitere Artikel der Ausgabe 3/2012

Breast Cancer Research and Treatment 3/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.